| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/07/2006 | US20060275297 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal |
| 12/07/2006 | US20060275296 Produced by hybridomas; antipruritic agents; blocks scratching, dermatitis, or hairloss |
| 12/07/2006 | US20060275292 Fully human anti-CD3 monoclonal antibodies |
| 12/07/2006 | US20060275291 Identification of Unique Binding Interactions Between Certain Antibodies and the Human B7.1 and B7.2 Co-Stimulatory Antigens |
| 12/07/2006 | US20060275290 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 12/07/2006 | US20060275289 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 12/07/2006 | US20060275288 GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof |
| 12/07/2006 | US20060275287 Scroll compressor |
| 12/07/2006 | US20060275286 Monoclonal antibody named KIS-1N produced by the hybridoma cell line; for development of an agent for the diagnosis and prevention/treatment of diseases (cancer, and so forth) associated with the polypeptide |
| 12/07/2006 | US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination |
| 12/07/2006 | US20060275283 Fcgamma receptor-binding polypeptide variants and methods related thereto |
| 12/07/2006 | US20060275282 Antibodies and Fc fusion proteins with altered immunogenicity |
| 12/07/2006 | US20060275258 Interferon-alpha induced gene |
| 12/07/2006 | US20060275256 Inhibition of pathogenic agents including alpha6beta1 integrin receptor of alpha6beta4 integrin receptor at a surface |
| 12/07/2006 | US20060275254 covalently linked to a drug that is a physiologically active polypeptide through a non-peptide linker; nonimmunogenic; extended serum half-life of a drug while maintaining the in vivo activity |
| 12/07/2006 | US20060275214 Methods of screening for anti-inflammatory drugs and use thereof |
| 12/07/2006 | US20060275212 Treatment and diagnosis of cancer |
| 12/07/2006 | US20060275211 Antibodies and related molecules that bind to 161P2F10B proteins |
| 12/07/2006 | US20060275210 inhibit proliferation of CK-B4 expression; used to diagnose, treat, prevent cancer, to inhibit the progression or metastasis of myeloproliferative and other disorders such as leukemia, T-cell lymphoma, and/or B-cell lymphoma |
| 12/07/2006 | CA2610234A1 Antibodies directed to cd20 and uses thereof |
| 12/07/2006 | CA2609600A1 Tweak binding antibodies |
| 12/07/2006 | CA2609554A1 Polyclonal antiserum against a universal tumor antigen |
| 12/07/2006 | CA2609262A1 Anti-cd14 antibody fusion protein |
| 12/07/2006 | CA2609234A1 Anti-il2 antibodies |
| 12/07/2006 | CA2607471A1 Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, production and use thereof |
| 12/06/2006 | EP1729135A2 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 12/06/2006 | EP1728864A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy |
| 12/06/2006 | EP1728802A2 ErbB3 antibodies |
| 12/06/2006 | EP1728801A1 Subtype of humanized antibody against interleukin-6 receptor |
| 12/06/2006 | EP1728518A1 Method of diagnosing monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 12/06/2006 | EP1728441A2 Plants which synthesise a modified starch, process for the production thereof and modified starch |
| 12/06/2006 | EP1728077A2 Method for determination and quantification of radiation or genotoxin exposure |
| 12/06/2006 | EP1727901A2 Materials and methods for treatment of cancer |
| 12/06/2006 | EP1727833A1 Recombinant polypeptides of the members of the tnf ligand family and use thereof |
| 12/06/2006 | EP1727831A1 Genes and polypeptides relating to prostate cancers |
| 12/06/2006 | EP1727828A1 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy |
| 12/06/2006 | EP1727564A1 Cd44-targeting for reducing/preventing ischemia-reperfusion-injury |
| 12/06/2006 | EP1727563A1 Method for amplifying therapeutic vaccine activity |
| 12/06/2006 | EP1629106A4 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-beta-PROTEINS (TGF-betas) IN CELLS |
| 12/06/2006 | EP1456222A4 Non-human primate fc receptors and methods of use |
| 12/06/2006 | EP1353688B1 Method and compositions for immunization with the pseudomonas v antigen |
| 12/06/2006 | EP1114830B1 Cerebral organic anion transporter and its gene |
| 12/06/2006 | EP1054971B1 Group b streptococcus antigens |
| 12/06/2006 | EP0910406B1 Recombinant canine herpesviruses |
| 12/06/2006 | EP0837934B1 Human vascular endothelial growth factor 2 |
| 12/06/2006 | EP0820598B1 Assaying protein fragments in body fluids |
| 12/06/2006 | EP0812333B1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
| 12/06/2006 | CN1875028A Seneca valley virus based compositions and methods for treating disease |
| 12/06/2006 | CN1874790A Therapeutic agent for mesothelioma |
| 12/06/2006 | CN1874788A Cd20结合分子 Cd20 binding molecules |
| 12/06/2006 | CN1873003A 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 12/06/2006 | CN1873002A 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 12/06/2006 | CN1287853C Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway |
| 12/05/2006 | US7145056 Production of antibodies using cre-mediated site-specific recombination |
| 12/05/2006 | US7144994 Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms |
| 12/05/2006 | US7144991 Use of fusion proteins, especially scFvSA, as diagnostic markers or as cell specific targeting agents. |
| 12/05/2006 | US7144990 Antibody to a polypeptide overexpressed in tumors |
| 12/05/2006 | US7144985 Diagnosis of diabetes using antibody |
| 12/05/2006 | US7144731 monoclonal antibody immunoreactive with a stem cell factor; hybridoma cell line; can stimulate growth of primitive progenitors including early hematopoietic progenitor cells |
| 12/05/2006 | US7144730 Lipoxygenase proteins and polynucleotides encoding the same |
| 12/05/2006 | US7144720 ADAM gene having a novel base sequence; an ADAM protein encoded by it has the protease activity and is involved in degradation of an extracellular matrix; recombinant vector comprising the DNA; recombinant host cell |
| 12/05/2006 | US7144704 Incubating mammalian cell expressing multidrug resistance gene or P-glycoprotein with immunological reagent specific for a biochemical conformation; evaluating binding; drug screening for anticarcinogenic agents |
| 12/05/2006 | US7144698 Postweaning multisystemic wasting syndrome virus from pigs |
| 12/05/2006 | US7144697 Synthetic antigen for the detection of antibodies immunoreactive with HIV virus |
| 12/05/2006 | US7144575 Methods for selectively stimulating proliferation of T cells |
| 12/05/2006 | CA2151945C Assay and treatment for demyelinating diseases such as multiple sclerosis |
| 11/30/2006 | WO2006128103A2 Humanized anti-cd40 antibodies and their methods of use |
| 11/30/2006 | WO2006128063A2 Methods and compositions for inhibiting glioma growth |
| 11/30/2006 | WO2006128027A1 Functionally active recombinant peptides, methods for producing same and interactions with other peptides |
| 11/30/2006 | WO2006128006A1 Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions |
| 11/30/2006 | WO2006127507A2 Compounds and methods for labeling oligonucleotides |
| 11/30/2006 | WO2006127020A1 FUNCTIONAL EPITOPES OF STREPTOCOCCUS PNEUMONIAE PsaA ANTIGEN AND USES THEREOF |
| 11/30/2006 | WO2006127008A1 Assay method for group transfer reactions |
| 11/30/2006 | WO2006126671A1 Improvement of disease resistance of plant by introducing transcription factor gene |
| 11/30/2006 | WO2006126287A1 Method for detecting hiv-1 and kit to be used for the method |
| 11/30/2006 | WO2006125921A2 Antibody or antibody fragment coupled with an immunogenic agent |
| 11/30/2006 | WO2006125914A2 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 11/30/2006 | WO2006125668A2 Anti-cd16 binding molecules |
| 11/30/2006 | WO2006125640A2 Generation and profiling of fully human hucal gold®-derived therapeutic antibodies specific for human cd38 |
| 11/30/2006 | WO2006125632A2 Agonistic antibodies that bind to the tweak receptor fn14 and thereby modulate adiposity-associated phenotypes as well as their use in therapy |
| 11/30/2006 | WO2006125599A2 Method for the purification of antibodies |
| 11/30/2006 | WO2006125481A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen |
| 11/30/2006 | WO2006108234A8 Modified animal lacking functional pyy gene, monoclonal antibodies that bind pyy isoforms and uses therefor |
| 11/30/2006 | WO2006099698A3 Novel anti-plgf antibody |
| 11/30/2006 | WO2006096488A3 Composition comprising human igg2 antibody and chelating agent |
| 11/30/2006 | WO2006095128A3 Rodent pest control |
| 11/30/2006 | WO2006084226A3 Antibodies that bind to epha2 and methods of use thereof |
| 11/30/2006 | WO2006072601A3 THERAPEUTIC USE OF GROWTH FACTORS, NsG29 AND NsG31 |
| 11/30/2006 | WO2006069403B1 Methods for producing soluble multi-membrane-spanning proteins |
| 11/30/2006 | WO2006046270A3 Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof |
| 11/30/2006 | WO2006042745A3 Chemically modified peptide analogs |
| 11/30/2006 | WO2005070965A3 Pharmaceutical compositions containing antagonists to lrp4, lrp8 or megalin for treatment of diseases |
| 11/30/2006 | WO2005069935A3 METHODS FOR MEASURING TRANSFORMING GROWTH FACTOR BETA (TGF-β) RECEPTOR SIGNALING ACTIVITY AND USES THEREOF |
| 11/30/2006 | WO2005021707A3 Severe acute respiratory syndrome dna vaccine compositions and methods of use |
| 11/30/2006 | WO2005020919A3 Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor |
| 11/30/2006 | WO2004047728A3 Compositions and methods for the treatment of immune related diseases |
| 11/30/2006 | US20060272036 Ruminant mhc class-i-like fc receptors |
| 11/30/2006 | US20060271309 Method of diagnosis of cancer based on gene expression profiles in cells |
| 11/30/2006 | US20060270840 Pentopyranosyl nucleic acid conjugates |
| 11/30/2006 | US20060270837 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders |